logo
Plus   Neg
Share
Email

Bayer Stock Up As U.S. Judge Cuts Roundup Jury Award

Shares of Bayer Group (BAYZF.PK,BAYRY.PK,BYR.L) were gaining around 2 percent in German trading after a U.S. judge Monday reduced jury award related to weedkiller Roundup to $25.3 million from $80.3 million.

In the case by a California man who blamed Roundup for his cancer, U.S. District Judge Vince Chhabria in California ruled that the March verdict was too high. Meanwhile, the judge rejected the company's bid for a new trial.

Bayer reportedly said that Chhabria's decision is a step in the right direction, but that it still plans to appeal.

According to the Judge, evidence against the Monsanto Co., which Bayer bought last year, supported the award. However, punitive damages was reduced to $20 million from $75 million, saying that the higher award was constitutionally impermissible.

Chhabria wrote, "Monsanto's conduct, while reprehensible, does not warrant a ratio of that magnitude, particularly in the absence of evidence showing intentional concealment of a known or obvious safety risk."

There are more than 13,400 cases against Bayer and Monsanto over Roundup, alleging that glyphosate, the herbicide's active ingredient, is not safe.

In Germany, Bayer shares were trading at 59.66 euros, up 1.76 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT